Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related ARWR
The News That Should Move Arrowhead Research Today
Arrowhead Research Shares Seeing Significant Short Interest
Related FMI
The Best Biotech ETF Isn't Always The Biggest
Wedbush Previews Foundation Medicine, Expects In-Line Earnings
Roche extends expiration of tender offer for Foundation Med shares (Seeking Alpha)

Analysts at Piper Jaffray initiated coverage on shares of Arrowhead Research (NASDAQ: ARWR) with an “overweight” rating. The target price for Arrowhead Research is set to $12. Arrowhead Research's shares closed at $7.87 on Friday.

Analysts at Goldman Sachs initiated coverage on shares of Foundation Medicine (NASDAQ: FMI) with a “neutral” rating. The target price for Foundation Medicine is set to $33. Foundation Medicine's stock closed at $33.99 on Friday.

JP Morgan initiated coverage on shares of Premier (NASDAQ: PINC) with an “overweight” rating. The target price for Premier is set to $36. Premier's shares closed at $31.66 on Friday.

Morgan Stanley initiated coverage on shares of Ophthotech (NASDAQ: OPHT) with an “overweight” rating. The target price for Ophthotech is set to $56. Ophthotech's shares closed at $29.25 on Friday.

Latest Ratings for ARWR

DateFirmActionFromTo
Jan 2015Deutsche BankDowngradesBuyHold
Oct 2014RBC CapitalDowngradesOutperformSector Perform
Oct 2014Deutsche BankMaintainsBuy

View More Analyst Ratings for ARWR
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (ARWR + FMI)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→